206 related articles for article (PubMed ID: 36877238)
1. A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy.
Qu Q; Lu M; Xu L; Zhang J; Liu M; Jiang J; Zhao X; Zhang X; Zhang T
Br J Radiol; 2023 Mar; 96(1144):20220739. PubMed ID: 36877238
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis.
Ahn SJ; Kim JH; Park SJ; Kim ST; Han JK
Abdom Radiol (NY); 2019 Feb; 44(2):539-548. PubMed ID: 30229421
[TBL] [Abstract][Full Text] [Related]
3. Nomogram for Predicting Microvascular Invasion in Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced MRI and Intravoxel Incoherent Motion Imaging.
Zhou L; Qu Y; Quan G; Zuo H; Liu M
Acad Radiol; 2024 Feb; 31(2):457-466. PubMed ID: 37491178
[TBL] [Abstract][Full Text] [Related]
4. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
[TBL] [Abstract][Full Text] [Related]
5. Microvascular invasion of small hepatocellular carcinoma can be preoperatively predicted by the 3D quantification of MRI.
Dong SY; Wang WT; Chen XS; Yang YT; Zhu S; Zeng MS; Rao SX
Eur Radiol; 2022 Jun; 32(6):4198-4209. PubMed ID: 35079885
[TBL] [Abstract][Full Text] [Related]
6. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma.
Lee S; Kim SH; Lee JE; Sinn DH; Park CK
J Hepatol; 2017 Sep; 67(3):526-534. PubMed ID: 28483680
[TBL] [Abstract][Full Text] [Related]
7. Radiomic analysis based on multi-phase magnetic resonance imaging to predict preoperatively microvascular invasion in hepatocellular carcinoma.
Li YM; Zhu YM; Gao LM; Han ZW; Chen XJ; Yan C; Ye RP; Cao DR
World J Gastroenterol; 2022 Jun; 28(24):2733-2747. PubMed ID: 35979164
[TBL] [Abstract][Full Text] [Related]
8. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
[TBL] [Abstract][Full Text] [Related]
9. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
10. Prediction for Aggressiveness and Postoperative Recurrence of Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
Lu M; Qu Q; Xu L; Zhang J; Liu M; Jiang J; Shen W; Zhang T; Zhang X
Acad Radiol; 2023 May; 30(5):841-852. PubMed ID: 36577606
[TBL] [Abstract][Full Text] [Related]
11. Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy.
Yan M; Zhang X; Zhang B; Geng Z; Xie C; Yang W; Zhang S; Qi Z; Lin T; Ke Q; Li X; Wang S; Quan X
Eur Radiol; 2023 Jul; 33(7):4949-4961. PubMed ID: 36786905
[TBL] [Abstract][Full Text] [Related]
12. LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
Wei H; Jiang H; Zheng T; Zhang Z; Yang C; Ye Z; Duan T; Song B
Eur Radiol; 2021 Apr; 31(4):2289-2302. PubMed ID: 33001306
[TBL] [Abstract][Full Text] [Related]
13. VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC.
Jiang H; Wei H; Yang T; Qin Y; Wu Y; Chen W; Shi Y; Ronot M; Bashir MR; Song B
Radiology; 2023 Apr; 307(2):e221835. PubMed ID: 36786702
[TBL] [Abstract][Full Text] [Related]
14. MRI Features for Predicting Microvascular Invasion and Postoperative Recurrence in Hepatocellular Carcinoma Without Peritumoral Hypointensity.
Chen Z; Li X; Zhang Y; Yang Y; Zhang Y; Zhou D; Yang Y; Zhang S; Liu Y
J Hepatocell Carcinoma; 2023; 10():1595-1608. PubMed ID: 37786565
[TBL] [Abstract][Full Text] [Related]
15. The role of gadoxetic acid-enhanced MRI features for predicting microvascular invasion in patients with hepatocellular carcinoma.
Yang H; Han P; Huang M; Yue X; Wu L; Li X; Fan W; Li Q; Ma G; Lei P
Abdom Radiol (NY); 2022 Mar; 47(3):948-956. PubMed ID: 34962593
[TBL] [Abstract][Full Text] [Related]
16. Hepatobiliary Phase Features of Preoperative Gadobenate-Enhanced MR can Predict Early Recurrence of Hepatocellular Carcinoma in Patients Who Underwent Anatomical Hepatectomy.
Liu W; Song K; Zheng W; Huo L; Zhang S; Xu X; Wang P; Jia N
Front Oncol; 2022; 12():862967. PubMed ID: 35992871
[TBL] [Abstract][Full Text] [Related]
17. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
[TBL] [Abstract][Full Text] [Related]
18. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
20. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.
Zhou L; Rui JA; Zhou WX; Wang SB; Chen SG; Qu Q
Pathol Res Pract; 2017 Jul; 213(7):824-830. PubMed ID: 28554743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
